Leading Pathology Lab Safeguards Sensitive Patient Data with the Enterprise Immune System

MetroPath Embraces Disruptive AI Technology to Defend Against Fast-Moving Cyber-Threats

San Francisco
Monday August 21, 2017

Darktrace, the world leader in AI technology for cyber defense, has today announced that Metropolitan Pathologists (MetroPath) has deployed its disruptive AI technology to detect cyber-threats at their earliest stages, while providing comprehensive visibility of its entire network infrastructure.

“With new, automated, fast-acting attacks targeting the healthcare industry every day and bypassing traditional defenses, we knew we needed to take a fundamentally different approach to cyber security,” commented Jimmy Gelhaar, Director of IT, MetroPath. “Darktrace’s AI technology has proven instrumental in providing visibility of devices we didn’t even know we had on our network. Armed with the Enterprise Immune System, we can now detect and mitigate in-progress attacks before they escalate into a crisis.”

As the oldest private pathology lab in the State of Colorado, MetroPath has been instrumental in developing, advancing and innovating anatomic pathology services for over one hundred years. With its network overseeing the critical medical information of thousands of individuals, MetroPath considers safeguarding this sensitive patient information a mission-critical business priority. Of particular concern are phishing attempts that can trick employes into inadvisable actions, and brute-force, fast-spreading attacks such as ransomware that can wreak havoc on a network in mere minutes.

To meet these challenges, MetroPath deployed Darktrace’s Enterprise Immune System into the heart of its network. The AI algorithms started self-learning the normal ‘pattern of life’ of every user and device on the network and were able to quickly detect a threatening anomaly within the network: a workstation was making an unknown data transfer to a remote location in the middle of the night. Darktrace alerted the security team instantly, as the time, size, and destination of the data transfer deviated from the network’s expected ‘pattern of life’. Because of Darktrace’s early threat detection capabilities, MetroPath was able to instantly remediate the situation before any damage could be done.

“Healthcare organizations are particularly vulnerable to fast-moving attacks like WannaCry,” commented Rob Sass, Managing Director, North America. “Although there is no silver bullet for cyber security, companies are turning to crucial AI technology that is capable of identifying and neutralizing these automated attacks. True to its long-standing tradition of being an innovator in its field, MetroPath is leading the charge in adopting pioneering AI technology to stay abreast of this escalated cyber climate.”

To learn more about MetroPath’s security initiatives, download the case study or watch the video on our Video Case Studies page.

About Darktrace

Darktrace is the world’s leading machine learning company for cyber security. Created by mathematicians from the University of Cambridge, the Enterprise Immune System uses AI algorithms to automatically detect and take action against cyber-threats within all types of networks, including physical, cloud and virtualized networks, as well as IoT and industrial control systems. A self-configuring platform, Darktrace requires no prior set-up, identifying advanced threats in real time, including zero-days, insiders and stealthy, silent attackers. Headquartered in San Francisco and Cambridge, UK, Darktrace has 24 offices worldwide.